1-6 of 6
Björn Wahlin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A CX3CR1 (fractalkine receptor) Small Molecular Antagonist (KAND567) Suppressed the Growth Promoting Effect of Monocytes on Chronic Lymphocytic Leukemia Cells

Mohammad Hojjat-Farsangi, Wen Zhong, Tom Mulder, Ann Svensson, Jeanette Lundin, Marzia Palma, Johan Schultz, Thomas Olin, Bjorn Wahlin, Anders Osterborg, Parviz Kokhaei, Hakan Mellstedt
Journal: Blood
Blood (2023) 142 (Supplement 1): 5716.
https://doi.org/10.1182/blood-2023-185953
Published: 2023
Journal Articles

Good Outcome after R-Hyper-CVAD/R-MA in High-Risk Aggressive B-Cell Lymphoma: A Single-Center Experience

Kristina Sonnevi, Maria Ljungqvist, Joel K Joelsson, Sara Harrysson, Tove Wästerlid, Per Bernell, Björn Wahlin
Journal: Blood
Blood (2021) 138 (Supplement 1): 4587.
https://doi.org/10.1182/blood-2021-144440
Published: 2021
Journal Articles

Event-Free and Overall Survival in over 6,000 Patients Treated with Frontline Immunochemotherapy for Follicular Lymphoma between 2002-2018: First Report from the International FLIPI24 Consortium

Matthew J. Maurer, Vit K Prochazka, Christopher R. Flowers, Lasse H. Jakobsen, Diego Villa, Caroline Weibull, Elliot J. Cahn, Herve Ghesquieres, Robert Kridel, Maher Gandhi, Chan Yoon Cheah, Eliza Hawkes, John F. Seymour, Ciara L. Freeman, Michael Roost Clausen, Björn Wahlin, Brian K. Link, Karin Ekstroem Smedby, Laurie H. Sehn, Marek Trněný, Tarec Christoffer El-Galaly, James R. Cerhan
Journal: Blood
Blood (2021) 138 (Supplement 1): 3527.
https://doi.org/10.1182/blood-2021-145883
Published: 2021
Journal Articles

Subcutaneous Epcoritamab in Combination with R 2 (Rituximab and Lenalidomide) in Patients with Relapsed or Refractory Follicular Lymphoma: Preliminary Results from a Phase 1/2 Trial

Kim M Linton, Björn Wahlin, Sirpa Leepä, Franck Morschhauser, Brian Elliot, Tracy Liu, Mariana Cota Stirner, Aqeel Abbas, Lorenzo Falchi
Journal: Blood
Blood (2021) 138 (Supplement 1): 3535.
https://doi.org/10.1182/blood-2021-146629
Published: 2021
Journal Articles

Efficacy and Safety of Parsaclisib in Patients with Relapsed or Refractory Follicular Lymphoma: Primary Analysis from a Phase 2 Study (CITADEL-203)

Ryan C. Lynch, Abraham Avigdor, Matthew S McKinney, Shankara Paneesha, Björn Wahlin, John S Hrom, David Cunningham, Nicholas Morley, Miguel Canales, Mariana Bastos-Oreiro, David Belada, Liliana Devizzi, Fred Zheng, Douglas J DeMarini, Wei Jiang, Marek Trněný
Journal: Blood
Blood (2021) 138 (Supplement 1): 813.
https://doi.org/10.1182/blood-2021-147918
Published: 2021
Journal Articles

Pre-Transplant Hyperferritinemia Is Associated with Low Incidence of Chronic Gvhd, High Relapse Rate and Impaired Survival in Patients with Hematological Malignancies after Allogeneic HSCT

Hans Gustaf Hagglund, Fryderyk Lorenz, Mats Remberger, Bjorn Wahlin, Anders Wahlin
Journal: Blood
Blood (2008) 112 (11): 4299.
https://doi.org/10.1182/blood.V112.11.4299.4299
Published: 2008